DUBLIN--(BUSINESS WIRE)--The "Global Dietary Supplements Market Analysis (2017-2023)" report has been added to ResearchAndMarkets.com's offering.
The Global Dietary Supplements Market size is expected to reach $245.6 billion by 2023, rising at a market growth of 10% CAGR during the forecast period.
Dietary supplements are growing as a vital component within a diet plan of individuals, and these supplements are consumed to provide essential nutritional components, which otherwise is expected to be missing. Growing prevalence of cardiovascular disorders on account of fluctuating diet patterns and inactive lifestyle among the age-group of 30-40 is expected to drive the nutraceuticals market. Awareness about calorie reduction among athletes and gym goers is expected to promote the adoption of supplements within the sports segment.
Based on Product, the Dietary Supplements market segments the market into Tablets & Capsules, Powder, Liquids, Soft Gels, and Others. Based on Ingredients, the market report segments the market into Vitamins & Minerals, Botanicals, Amino Acids, and Enzymes & Others. Based on End User, the Dietary Supplements market segments the market into Adults, Children, Infants & Old Aged, and Pregnant Woman. Based on Regions, the Dietary Supplements market segments the market into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa
- Abbott Laboratories
- The Carlyle Group
- GlaxoSmithKline plc
- Bayer AG
- Archer Daniels Midland Company
- E. I. Du Pont De Nemours and Company
- Nutraceutics Inc.
- Pfizer, Inc.
Key Topics Covered:
1. Market Scope & Methodology
2. Market Overview
3. Global Dietary Supplements Market
4. Global Dietary Supplements Market by Ingredients
5. Global Dietary Supplements Market by End User
6. Global Dietary Supplements Market by Region
7. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/djbnxz/global_dietary?w=4